Results: 1-9 |
Results: 9

Authors: Tcheng, JE Strony, J Lorenz, TJ O'Shea, JC
Citation: Je. Tcheng et al., ESPRIT in context: pharmacology matters!, EUR HEART J, 22(21), 2001, pp. 1965-1967

Authors: O'Shea, JC Hafley, GE Greenberg, S Hasselblad, V Lorenz, TJ Kitt, MM Strony, J Tcheng, JE
Citation: Jc. O'Shea et al., Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention - The ESPRIT trial: A randomized controlled trial, J AM MED A, 285(19), 2001, pp. 2468-2473

Authors: Gilchrist, IC O'Shea, JC Kosoglou, T Jennings, LK Lorenz, TJ Kitt, MM Kleiman, NS Talley, D Aguirre, F Davidson, C Runyon, J Tcheng, JE
Citation: Ic. Gilchrist et al., Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention, CIRCULATION, 104(4), 2001, pp. 406-411

Authors: Tcheng, JE Talley, JD O'Shea, JC Gilchrist, IC Kleiman, NS Grines, CL Davidson, CJ Lincoff, AM Califf, RM Jennings, LK Kitt, MM Lorenz, TJ
Citation: Je. Tcheng et al., Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study), AM J CARD, 88(10), 2001, pp. 1097-1102

Authors: Tcheng, JE O'Shea, JC Cohen, EA Pacchiana, CM Kitt, MM Lorenz, TJ Greenberg, S Strony, J Califf, RM Buller, C Cantor, WJ Joseph, DM Kitt, MM Lincoff, AM Madan, M Popma, J Teirstein, P Cohen, E Balleza, L Parsons, P Lui, H Young, J Fox, R Labinaz, M Jelley, J Williams, J Cohen, D Trovato, M Smith, J Henry, P Chisholm, R O'Donnell, D Talley, JD Pacheco, R Timmis, S Muraka, A Mann, T Cubeddu, G Tannenbaum, M Greene, J Santoian, E Wash, M Sheldon, S Pronesti, L Jain, A Alonzo, M Seidelin, P Richards, J Lopez, M Dittenber, R Johnson, K Levine, G Maresh, K Ferrando, T Sarembock, I Snyder, L Kieval, J Herlan, L Miller, M Bembridge, D Nair, R Hickel, L Kiernan, F Murphy, D Cloutier, J Conn, E Beardsley, J Ritchie, M Cragen, D Jafar, MZ Counihan, P Rosenfelder, D Ducas, J Montebruno, L Carere, R Radons, B Williams, L Owens, W Dougal, R Feldman, R Audrain, D Karamali, A Smith, M Blankenship, J Demko, SL Thompson, M Gacoich, G Chiodo, V Noll, P Ledley, G Miller, C Felten, W Garner, B Chandler, AB Easler, P Albin, G Page, A Maddox, W Allen, S Gilchrist, I Moore, R Zimmerman, H Curtis, M Hildebrand, K Greene, R Healy, E Meengs, W Carson, D George, J Roncevich, T Aharonian, V Browning, R Kostuk, W Carr, S Feit, F Gostomsky, B Butman, S Hannah, E Hassel, CD Hartley, D Shook, T Hiller-Mullin, S Brill, D Dillion, M Armstrong, B Kerns, D Pichard, A Okubagzi, P Nasser, T Driver, L Garrett, J Boltey, L Stouffer, G Potter, M Amidon, T Eggert, S Taussig, A Potter, K Natarajan, M Tartaglia, C Werner, J Dunlap, T Harrold-Runge, P Davidson, C Goodreau, L Herzog, W Calamunci, N Slater, A Tormey, D Phillips, W White, D Sridhar, K White, J Goodman, D Buchbinder, M Nasser, V Rapeport, K Vorman, P Weiner, B Borbone, M Shadoff, N Paap, C Rehman, A Haag, E Burchenal, J Kioussopoulos, K Senior, D Senior, J Piana, R Kirshenbaum, J Chan, S Chowdry, A Kraft, P Clark, V Fox, M Deutsch, E Shannon, T Quesada, R Brotherton, J Murrin, C Cinderella, J Hearne, S Seefried, V Farah, T Pakstis, D Bartolet, B Bond, C Debarardinis, C Montory, D Smith, G Gray, D Phillips, P Hathaway, S Manoukian, S Patrick, C Yakubov, S Brooks, J Block, P Block, B Muhlestein, JB Kim, S Shalev, Y Schmidt, W Resar, J Citro, K Stine, R Zumbuhl, J Moreyra, A Kreiger, S Berger, P Cannon, CP Fisher, L Hasselblad, V Foster, A Joseph, D Madan, M McLendon, C Rund, M Tillery, N Wood, F Mahaffey, KW Irwin, C Kulick, D Johnson, N Chen, J Greenberg, S Hogeboom, C Lorenz, TJ Terifay, R Strony, J Veltri, E
Citation: Je. Tcheng et al., Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, LANCET, 356(9247), 2000, pp. 2037-2044

Authors: Kleiman, NS Lincoff, AM Flaker, GC Pieper, KS Wilcox, RG Berdan, LG Lorenz, TJ Cokkinos, DV Simoons, ML Boersma, E Topol, EJ Califf, RM Harrington, RA
Citation: Ns. Kleiman et al., Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes, CIRCULATION, 101(7), 2000, pp. 751-757

Authors: Dyke, CM Bhatia, D Lorenz, TJ Marso, SP Tardiff, BE Hogeboom, C Harrington, RA
Citation: Cm. Dyke et al., Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: Results from PURSUIT, ANN THORAC, 70(3), 2000, pp. 866-871

Authors: O'Shea, JC Madan, M Cantor, WJ Pacchiana, CM Greenberg, S Joseph, DM Kitt, MM Lorenz, TJ Tcheng, JE
Citation: Jc. O'Shea et al., Design and methodology of the ESPRIT trial: Evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention, AM HEART J, 140(6), 2000, pp. 834-839

Authors: Lorenz, TJ Macdonald, F Kitt, MM
Citation: Tj. Lorenz et al., Nonimmunogenicity of eptifibatide, a cyclic heptapeptide inhibitor of platelet glycoprotein IIb-IIIa, CLIN THER, 21(1), 1999, pp. 128-137
Risultati: 1-9 |